08.26.25 -- Meet Top CDMOs With Available Capacity For Tailored Solutions

Hear from Evan Pasenello, Head of Commercial Services, about how Resilience can support large molecule programs from early phase through clinical and commercial manufacturing.

Explore the strategic application of extensive expertise in microbial systems to meet increasing demand. Cutting-edge capabilities ensure streamlined development and manufacturing processes.

Aragen’s newly built cutting-edge biologics manufacturing facility launches with GMP capabilities from 50L to 2000L with a DP filling line and ADC conjugation suite set to redefine bioproduction in India.

Thomas Kohl, Director of Business Development, shares microbial and mammalian capabilities and available capacity. Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients.

Review biologics CDMO solutions and capacity offered by Novartis Contract Manufacturing. Discover capabilities in mammalian cell culture manufacturing and microbial fermentation.

With more than 65 years of sterile injectable manufacturing experience, Simtra offers world-class GMP sterile fill/finish services, deep scientific and technical expertise, and a uniquely collaborative approach.

Leveraging Lonza's deep ADC expertise and experience, successfully develop high quality, commercially viable processes, spanning from pre-clinical development through commercial scale manufacturing.

With more than 15 years of experience as conjugation and linker-payload CDMO, MilliporeSigma has a proven track record of supporting clinical programs from IND to PPQ for commercialization.

Gain an overview of a new state-of-the-art Groninger filling line’s capabilities, production scale-up timelines, and how this new infrastructure supports product flexibility and long-term growth.

Novartis Contract Manufacturing introduces their fill and finish solutions and capacity. Explore an overview of the aseptic network of Novartis and the capabilities of each site.

PCI is positioned to meet the future of sterile pharmaceutical development and manufacturing with technology and solutions for high-value biologics, complex formulations, and lyophilized drug products.

INCOG's balanced framework addresses the unique challenges of sterile manufacturing by integrating risk-based decision making with systematic capacity planning.

Pedro Morales, Director, Scientific Advisor of Biologics Analytical Services, explores how Catalent delivers tailored solutions through deep expertise and advanced capabilities.

Explore real examples of how KBI Biopharma has supported its partners through transparency that empowers, integration that simplifies, methods that de-risk, and experience that accelerates.

Alcami’s laboratory services can support many drug substance or drug product modalities, all product phases, and more, including in-house microbiology, raw materials, and analytical development.